The application of breast MRI in staging and screening for breast cancer

ONCOLOGY

Volumn 19, Issue 2, 2005, Pages 159-169

  Gundry, Kathleen R ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST BIOPSY; BREAST CANCER; BREAST DISCHARGE; BREAST EXAMINATION; BREAST SURGERY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; CONTRAST ENHANCEMENT; COST BENEFIT ANALYSIS; DRUG INHIBITION; ECHOMAMMOGRAPHY; FOLLOW UP; HUMAN; LUNG CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; REVIEW; TREATMENT RESPONSE; BREAST TUMOR; CLASSIFICATION; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 19444372566     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Kaiser W, Zeitler E: MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681-686, 1989.
2. Heywang S, Wolf A, Pruss E, et al: MR imaging of the breast with Gd-DTPA: Use and limitations. Radiology 171:95-103, 1989.
3. Passe T, Bluemke D, Siegelman S: Tumor angiogenesis: Tutorial on implications for imaging. Radiology 203:593-600, 1997.
4. Teifke A, Hlawatsch A, Beier T, et al: Undetected Malignancies of the Breast: Dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 224:881-888, 2002.
5. Kinkel K, Helbich TH, Esserman LJ, et al: Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: Diagnostic criteria and interobserver variability. Am J Roentgenol 175:35-43, 2000.
6. Harms S, Flamig D, Hesley K, et al: MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 187:493-501, 1993.
7. Hlawatsch A, Teifke A, Schmidt M, et al: Preoperative assessment of breast cancer: Sonography versus MR imaging. AJR Am J Roentgenol 179:1493-1501, 2002.
8. Boetes C, Mus R, Holland R, et al: Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743-747,1995.
9. Liberman L, Morris EA, Kim CM, et al: MR Imaging findings in the contralateral breast of women with recently diagnosed breast cancer. Am J Roentgenol 180:333-341, 2003.
10. Krecke K, Gisvold J: Invasive lobular carcinoma of the breast: Mammographic findings and extent of disease at diagnosis in 184 patients. Am J Roentgenol 161:957-960, 1993.
11. Butler R, Venta L, Wiley E, et al: Sonographic evaluation of infiltrating lobular carcinoma. Am J Roentgenol 172:325-330, 1999.
12. Quan ML, Sclafani L, Heerdt AS, et al: Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol 10:1048-1053, 2003.
13. Weinstein SP, Orel SG, Heller R, et al: MR imaging of the breast in patients with invasive lobular carcinoma. Am J Roentgenol 176:399-406, 2001.
14. Rodenko G, Harms S, Pruneda J, et al: MR imaging in the management before surgery of lobular carcinoma of the breast: Correlation with pathology. Am J Roentgenol 167:1415-1419, 1996.
15. Qayyum A, Birdwell RL, Daniel BL, et al: MR imaging features of infiltrating lobular carcinoma of the breast: Histopathologic correlation. Am J Roentgenol 178:1227-1232, 2002.
16. Bedrosian I, Mick R, Orel S, et al: Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98:468-473, 2003.
17. Lee SG, Orel SG, Woo U, et al: MR Imaging screening of the contralateral breast in patients with newly diagnosed breast cancer Preliminary results. Radiology 226:773-778, 2003.
18. Baron PL, Moore MP, Kinne DW, et al: Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 125:210-214, 1990.
19. Olson JA Jr, Morris EA, Van Zee KJ, et al: Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 7:411-415, 2000.
20. Orel SG, Weinstein SP, Schnall MD, et al: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212:543-549,1999.
21. Inaji H, Komoike Y, Motomura K, et al: Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer. Breast Cancer 9:20-25, 2002.
22. Rosen EL, Blackwell KL, Baker JA, et al: Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 181:1275-1282, 2003.
23. Partridge SC, Gibbs JE, Lu Y, et al: Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. Am J Roentgenol 179:1193-1199, 2002.
24. Vinnicombe S, MacVicar A, Guy R, et al: Primary breast cancer: Mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 198:333-340, 1996.
25. Segel M, Paulus D, Hortobagyi G: Advanced primary breast cancer: Assessment at mammography of response to induction chemotherapy. Radiology 169:49-54, 1988.
26. Rieber A, Brambs H, Gabelmann A, et al: Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 12:1711-1719, 2001.
27. Lee C, Smith R, Levine J, et al: Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. Am J Roentgenol 173:1323-1329, 1999.
28. Warren RM, Crawley A: Is breast MRI ever useful in a mammogrpahic screening programme? Clin Radiol 57:1090-1097, 2002.
29. Sakuhara Y, Shinozaki T, Hozumi Y, et al: MR imaging of diabetic mastopathy. Am J Roentgenol 179:1201-1203, 2002.
30. Lee JM, Orel SG, Czerniecki BJ, et al: MRI before reexcision surgery in patients with breast cancer. Am J Roentgenol 182:473-480, 2004.
31. Frei K, Kinkel K, Bond H, et al: MR imaging of the breast with positive margins after lumpectomy: Influence of the time interval between lumpectomy and MR imaging. Am J Roentgenol 175:1577-1584, 2000.
32. Rieber A, Schramm K, Helms G, et al: Breast-conserving surgery and autogenous tissue reconstruction in patients with breast cancer: Efficacy of MRI of the breast in the detection of recurrent disease. Eur Radiol 13:780-787, 2003.
33. Morakkabati N, Leutner CC, Schmiedel A, et al: Breast MR imaging during or soon after radiation therapy. Radiology 229:893-901, 2003.
34. Kuhl CK, Schmutzler RK, Leutner CC, et al: Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results. Radiology 215:267-279, 2000.
35. Morris EA, Liberman L, Ballon DJ, et al: MRI of cccult breast carcinoma in a high-risk population. Am J Roentgenol 181:619-626, 2003.
36. Stoutjesdijk MJ, Boetes C, Jager GJ, et al: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93:1095-1102, 2001.
37. Tilanus-Linthorst M, Obdeeijn I, Bartels K, et al: First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res 63:53-60, 2000.
38. Warner E, Plewes D, Shumak G, et al: Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19:3524-3531, 2001.
39. Kriege M, Brekelmans CTM, Boetes C, et al: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004.
40. Kuhl C, Bieling H, Gieseke J, et al: Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical- phase dependency. Radiology 203:137-144, 1997.
41. Teifke A, Lehr HA, Vomweg TW, et al: Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. Am J Roentgenol 181:655-662, 2003.
42. Brown J, Smith R, Lee C: Incidental enhacing lesions found on MRI imaging of the breast. Am J Roentgenol 176:1249-1254, 2001.
43. Warren R, Pointon L, Caines R, et al: What is the recall rate of breast MRI when used for screening aymptomatic women at hig hisk? Magn Reson Imaging 20:557-565, 2002.
44. Liberman L, Morris EA, CL B, et al: Probably benign lesions at breast magnetic resonance imaging: Preliminary experience in high-risk women. Cancer 98:377-388, 2003.
45. Lee C, Weinreb J: The use of magnetic resonance imaging in breast cancer screening. J Am Coll Radiol 1:176-182, 2004.
46. Orel S, Mendonca M, Reynolds C, et al: MR imaging of ductal carcinoma in situ. Radiology 202:413-420, 1997.
47. Kinkel K, Hylton N: Challenges to interpretation of breast MRI. J Magn Reson Imaging 13:821-829, 2001.
48. Westerhof J, Fischer U, Moritz J, et al: MR imaging of mammographically detected clustered microcalcifications: Is there any value? Radiology 207:675-681, 1998.
49. Murphy K, Brunberg J, Cohan R: Adverse reactions to gadolinium contrast media: A review of 36 cases. Am J Roentgenol 167:847-849, 1996.
50. Cochran ST, Bomyea K, Sayre JW: Trends in adverse events After IV administration of contrast media. Am J Roentgenol 176:1385-1388, 2001.
51. Fischer U, Vosshenrich R, Doler W, et al: MR imaging-guided breast intervention: Experience with two systems. Radiology 195:533-538, 1995.
52. Morris EA, Liberman L, Dershaw DD, et al: Preoperative MR imaging - guided needle localization of breast lesions. Am J Roentgenol 178:1211-1220, 2002.
53. Kuhl C, Elevelt A, Leutner C, et al: Interventional breast MR imaging: Clinical use of a stereotactic localization and biopsy device. Radiology 204:667-675, 1997.
54. Kuhl CK, Morakkabati N, Leutner CC, et al: MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology 220:31-39, 2001.
55. Liberman L, Morris EA, Dershaw DD, et al: Fast MRI-guided vacuum-assisted breast biopsy: Initial experience. Am J Roentgenol 181:1283-1293, 2003.
56. Ikeda D, Hylton N, Kinkel K, et al: Developement, standardization and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13:889-895, 2001.
57. Sinha S, Sinha U: Functional magnetic resonance of human breast tumors. Ann N Y Acad Sci 980:95-111, 2002.
58. Tse GMK, Cheung HS, Pang L-M, et al: Characterization of lesions of the breast with proton MR spectroscopy: Comparison of carcinomas, benign lesions, and phyllodes tumors. Am J Roentgenol 181:1267-1272, 2003.